EvolveImmune Therapeutics

Reimagining Cancer Immunotherapy

BRANFORD, United States · Founded 2019 · $37.0M raised

Employees
51–200
Founded
2019
Business Model
B2B
Total Funding
$37.0M
Last Round
$37.0M Venture RoundDec 2023
Rounds
1

About

EvolveImmune Therapeutics is a privately-held immuno-oncology company founded in 2019 and headquartered in Branford, Connecticut. The company's EVOLVE platform pioneers a new class of trispecific T cell engager therapies that integrate CD2 costimulation to overcome tumor resistance mechanisms that limit current immunotherapies. Its lead clinical asset, EVOLVE104, initiated a Phase 1 trial in patients with solid tumors in December 2025. EvolveImmune has partnered with AbbVie to develop additional therapeutics leveraging its costimulation technology, and counts Pfizer Ventures among its investors. The company was founded out of the Sidi Chen Lab at Yale University and is led by co-founder and CEO Sidi Chen.

Summary

EvolveImmune Therapeutics is a Biotech company based in BRANFORD, United States, founded in 2019. It has raised $37.0M in total across 1 round, most recently a $37.0M Venture Round round in Dec 2023. Investors include Pfizer Ventures, Solasta Ventures and Takeda (US).

Tech & App Stack

1 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundVenture RoundDec 2023
$37.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

EvolveImmune Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/evolveimmune-therapeutics"><img src="https://indexed.vc/api/badge/company/evolveimmune-therapeutics" alt="EvolveImmune Therapeutics on Indexed.vc" width="260" height="76" /></a>